AP NEWS

Reinvent Biologics Appoints David Drez, MD as a Chief Medical Officer

September 25, 2018

FORT WORTH, Texas--(BUSINESS WIRE)--Sep 25, 2018--Fort Worth-based Reinvent Biologics announced the appointment of David Drez Jr., MD as Chief Medical Officer.

As Chief Medical Officer, Drez will provide strategic leadership on all of Reinvent Biologics medical education and research activities. He will research and track current clinical trends and provide training and support to medical professionals to optimize patient outcomes with Reinvent Biologics products. He will also serve as a resource on Reinvent’s sales efforts.

With a career spanning more than 42 years, Dr. Drez is one of the nation’s leading experts in orthopedics and sports medicine. The co-author of the highly acclaimed Orthopedic Sports Medicine and co-editor of Operative Techniques in Sports Medicine, Drez was the 2017 recipient of the Jack Weakley Award of Distinction from the National Athletic Trainer’s Association for a lifetime of outstanding contributions directly impacting health care in the area of athletics, athletic training, or sports medicine. Drez served as a team physician at McNeese State University for 37 years and was inducted into the University’s Hall of Fame. The rehabilitation area of the University’s Sports Medicine Center was named in his honor.

“Dr. Drez has spent his career sharing his knowledge and experience with future generations of physicians. He is a man of great character with a passion to teach,” said Bryant Gaines, CEO of Reinvent Biologics. “Throughout his distinguished career, he has elevated the standard of care provided to the patient. With such a great amount of research coming out on regenerative medicine, Dr. Drez will put us in a position to digest the data and effectively disseminate the knowledge to our distributors and customers.”

Drez earned his undergraduate and medical degrees from Tulane University. He completed a residency in general surgery and in orthopedic surgery at Charity Hospital in New Orleans – Tulane Service. He has published a large body of peer-reviewed research that has focused primarily on athletic injuries and their prevention and treatment options, particularly injuries of the knee and shoulder. He served as a Clinical Professor of Orthopaedics at Louisiana State University School of Medicine in New Orleans and a Clinical Assistant Professor of Orthopaedic Surgery at Baylor College of Medicine in Houston.

“Working with Reinvent Biologics will give me the opportunity to connect orthopedic medicine and regenerative medicine,” said Drez. “It’s the right time to increase awareness of the true benefits of regenerative medicine.”

About Reinvent Biologics

Fort Worth-based Reinvent Biologics, LLC discovers, invents, develops, manufactures, and commercializes new and innovative products in the field of regenerative medicine. Our goal is to address serious medical conditions, across multiple and diverse therapeutic areas. We are focused on providing physicians cost effective treatment options while improving the standard of care through a complete offering of science based biologic solutions. Learn more at www.reinventbiologics.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180925005863/en/

CONTACT: Reinvent Biologics

Joe Moore, 817-736-1557

KEYWORD: UNITED STATES NORTH AMERICA TEXAS

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES RESEARCH SCIENCE

SOURCE: Reinvent Biologics, LLC

Copyright Business Wire 2018.

PUB: 09/25/2018 11:08 AM/DISC: 09/25/2018 11:08 AM

http://www.businesswire.com/news/home/20180925005863/en

AP RADIO
Update hourly